Interpace Biosciences Inc (IDXG)


Stock Price Forecast

March 26, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Interpace Biosciences Inc chart...

About the Company

We do not have any company description for Interpace Biosciences Inc at the moment.

Please visit https://www.interpacediagnostics.com/ for more information about the company.

Sector

Manufacturing

Industry

Dental Laboratories

Employees

178

CEO

Jack Stover

Exchange

OTCQX MARKETPLACE

Website

https://www.interpacediagnostics.com/

$27M

Total Revenue

178

Employees

$20M

Market Capitalization

-0.59

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $IDXG News

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results

21d ago, source: Business Insider

Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fourth quarter and full year ending December 31, 2023. For the fourth ...

Interpace Biosciences announces preliminary Q4 revenue of $10.3M

20d ago, source: Hosted on MSN

Interpace Biosciences on Thursday said for the fourth quarter, it reported revenue of $10.3 million and income from continuing operations of $0.8 million, a $2.2 million improvement over the prior ...

Interpace Biosciences Inc IDXG

22d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity Loans

1mon ago, source: ADVFN

Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it, along with its subsidiaries, has entered into a new $8 million term loan with BroadOak ...

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results

21d ago, source: Yahoo Finance

PARSIPPANY, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fourth quarter and ...

Interpace Biosciences, Inc. (IDXG)

1y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results

21d ago, source: Stockhouse

Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fourth quarter and full year ending ...

Interpace Biosciences Inc.

3y ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Interpace Biosciences Inc. (IDXG)

1y ago, source: Nasdaq

Nasdaq Official Closing Price (NOCP)" is a process for identifying the Nasdaq market-specific closing price for Nasdaq-listed issues. Data provided by Nasdaq Data Link, a premier source for ...

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results

21d ago, source: Yahoo Finance

PARSIPPANY, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fourth quarter and full year ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...